Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®Risk Stratification Models for Precursor Diseases in Multiple Myeloma
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Expanding Endometrial Cancer Treatment Options: A Look into Trial Data
Project Oncology®Expanding Endometrial Cancer Treatment Options: A Look into Trial Data
The Evolving Landscape of Endometrial Cancer Treatments
Project Oncology®The Evolving Landscape of Endometrial Cancer Treatments
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
CME/CE Live BroadcastDifferentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
September 27, 2024
02:00 PM - 02:45 PM ET
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
CME/CE Live BroadcastDifferentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
October 25, 2024
11:00 AM - 11:45 AM ET
How Antibody-Based Therapies Are Revolutionizing Its Management
CME/CEHow Antibody-Based Therapies Are Revolutionizing Its Management
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
CME/CETargeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
Significance of HER2 Expression in Solid Tumors
MinuteCE®Significance of HER2 Expression in Solid Tumors
Helping Ensure Adequate Tissue Sampling Within the MDT
Medical Industry FeatureHelping Ensure Adequate Tissue Sampling Within the MDT
Managing Patients Within a Multidisciplinary Team Approach
Medical Industry FeatureManaging Patients Within a Multidisciplinary Team Approach
Pre-Testing: Working Together Toward Testing
Medical Industry FeaturePre-Testing: Working Together Toward Testing
Interpreting Test Results and Making the Treatment Decision Within the MDT
Medical Industry FeatureInterpreting Test Results and Making the Treatment Decision Within the MDT
Advocate for the Pathologist Within the MDT
Medical Industry FeatureAdvocate for the Pathologist Within the MDT
Navigating the Complexities of Sickle Cell Disease: An Expert Perspective
Medical Industry FeatureNavigating the Complexities of Sickle Cell Disease: An Expert Perspective
nih.gov
09/18/2024- medicalxpress.com
09/18/2024
- medicalxpress.com
09/18/2024
- medicalxpress.com
09/18/2024
- finance.yahoo.com
09/18/2024
- thestar.com.my
09/17/2024
